Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Hillert

Showing results (101-110 of 306) with videos related to

Pageof 31
Sort By:
Pharmacoeconomics - Open|June 13, 2019
Healthcare, Sickness Absence, and Disability Pension Cost Trajectories in the First 5 Years After Diagnosis with Multiple Sclerosis: A Prospective Register-Based Cohort Study in SwedenKorinna Karampampa, Hanna Gyllensten, Fei Yang, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|July 10, 2019
Costs of illness progression for different multiple sclerosis phenotypes: a population-based study in SwedenHanna Gyllensten, Andrius Kavaliunas, Chantelle Murley, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 21, 2015
Sources and level of income among individuals with multiple sclerosis compared to the general population: A nationwide population-based studyMichael Wiberg, Emilie Friberg, Magnus Stenbeck, et al.
Current Radiopharmaceuticals|November 15, 2011
Visualising neuroinflammation in post-stroke patients: a comparative PET study with the TSPO molecular imaging biomarkers [11C]PK11195 and [11C]vinpocetineBalazs Gulyas, Miklos Toth, Adam Vas, et al.
Annals of Clinical and Translational Neurology|January 2, 2020
Confounding effect of blood volume and body mass index on blood neurofilament light chain levelsAli Manouchehrinia, Fredrik Piehl, Jan Hillert, et al.
Neurology|February 23, 2024
Clinical Characteristics and Long-Term Outcomes of Late-Onset Multiple Sclerosis: A Swedish Nationwide StudyElena F Mouresan, Eleni Mentesidou, Anders Berglund, et al.
Respiratory Research|March 2, 2010
Different HLA-DRB1 allele distributions in distinct clinical subgroups of sarcoidosis patientsJohan Grunewald, Boel Brynedal, Pernilla Darlington, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|November 5, 2020
Cost-of-illness trajectories among people with multiple sclerosis by comorbidity: A register-based prospective study in SwedenGreta Bütepage, Ahmed Esawi, Kristina Alexanderson, et al.
JAMA Neurology|June 18, 2019
Long-term Cognitive Outcomes in Patients With Pediatric-Onset vs Adult-Onset Multiple SclerosisKyla A McKay, Ali Manouchehrinia, Lindsay Berrigan, et al.
JAMA Neurology|September 9, 2015
Effect of Smoking Cessation on Multiple Sclerosis PrognosisRyan Ramanujam, Anna-Karin Hedström, Ali Manouchehrinia, et al.
Pageof 31

Showing results (101-110 of 306) with videos related to

Sort By:
Pageof 31
Pharmacoeconomics - Open|June 13, 2019
Healthcare, Sickness Absence, and Disability Pension Cost Trajectories in the First 5 Years After Diagnosis with Multiple Sclerosis: A Prospective Register-Based Cohort Study in SwedenKorinna Karampampa, Hanna Gyllensten, Fei Yang, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|July 10, 2019
Costs of illness progression for different multiple sclerosis phenotypes: a population-based study in SwedenHanna Gyllensten, Andrius Kavaliunas, Chantelle Murley, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 21, 2015
Sources and level of income among individuals with multiple sclerosis compared to the general population: A nationwide population-based studyMichael Wiberg, Emilie Friberg, Magnus Stenbeck, et al.
Current Radiopharmaceuticals|November 15, 2011
Visualising neuroinflammation in post-stroke patients: a comparative PET study with the TSPO molecular imaging biomarkers [11C]PK11195 and [11C]vinpocetineBalazs Gulyas, Miklos Toth, Adam Vas, et al.
Annals of Clinical and Translational Neurology|January 2, 2020
Confounding effect of blood volume and body mass index on blood neurofilament light chain levelsAli Manouchehrinia, Fredrik Piehl, Jan Hillert, et al.
Neurology|February 23, 2024
Clinical Characteristics and Long-Term Outcomes of Late-Onset Multiple Sclerosis: A Swedish Nationwide StudyElena F Mouresan, Eleni Mentesidou, Anders Berglund, et al.
Respiratory Research|March 2, 2010
Different HLA-DRB1 allele distributions in distinct clinical subgroups of sarcoidosis patientsJohan Grunewald, Boel Brynedal, Pernilla Darlington, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|November 5, 2020
Cost-of-illness trajectories among people with multiple sclerosis by comorbidity: A register-based prospective study in SwedenGreta Bütepage, Ahmed Esawi, Kristina Alexanderson, et al.
JAMA Neurology|June 18, 2019
Long-term Cognitive Outcomes in Patients With Pediatric-Onset vs Adult-Onset Multiple SclerosisKyla A McKay, Ali Manouchehrinia, Lindsay Berrigan, et al.
JAMA Neurology|September 9, 2015
Effect of Smoking Cessation on Multiple Sclerosis PrognosisRyan Ramanujam, Anna-Karin Hedström, Ali Manouchehrinia, et al.
Pageof 31